Rizatriptan-Mepha oro 5 mg, Schmelztabletten
7680657990010
CH-65799
Schmelztabletten
Associated product:
RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 6
- Selling units
- 6
- Measure
- Tablette(n)
- Galenic form
- Schmelztabletten
- Galenic group
- Lutschtabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rizatriptanum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
rizatriptani benzoas
|
- | Substance | WIZUS |
|
mannitolum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
maltodextrinum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
saccharinum natricum
|
- | Substance | AIMDK |
|
natrium
|
0.03 MG | Substance | HBESI |
|
aromatica
|
- | Substance | AROMA |
|
amylum modificatum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 35.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/08/2015
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65799
- Drug name
- Rizatriptan-Mepha oro, Schmelztabletten
- Galenic form
- SCHM
- ATC Code
- N02CC04
- Authorization status
- Z
- Authorization category
- Category C
- Dispensing category
- B
- First authorization
- 22/05/2015
- Authorization expiration date
- 31/12/9999
- IT Number
- 02.05.1.
- Domain
- Human medicine
Package details
- Description (FR)
- RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
- Description (DE)
- RIZATRIPTAN Mepha oro Schmelztabl 5 mg 6 Stk
- Market launch
- 22/05/2015
- Narcotic (BTM)
- No
Original drug
Maxalt lingual, Schmelztabletten
GTIN: 7680545910120
CHF 38.45